Riskpilot← Back to searchSign inGet full accessSPECIALLÆGE, PH.D. BO KARLSMOSE ApS
APSActiveCVR 14711481Åboulevarden 17A, 1. thMedical specialists activities · NACE 8622Est. 199027 employees
Revenue 2025
DKK 9,2M
+16% vs 2024
EBITDA margin
25.9%
-16% vs 2024
Equity ratio
56.8%
Financial strength
Net profit 2025
DKK 1,6M
-18% vs 2024
| Revenue | DKK 9,2M | +16% |
| EBITDA | DKK 2,4M | -16% |
| Net profit | DKK 1,6M | -18% |
| Total assets | DKK 3,1M | -11% |
| Equity | DKK 1,8M | -17% |
| Employees | 27 | — |
Legal name
SPECIALLÆGE, PH.D. BO KARLSMOSE ApS
CVR number
14711481
Legal form
Anpartsselskab
NACE code
8622 · Medical specialists activities
Founded
1. september 1990
Share capital
DKK 125.000
Employees
27 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene
Company purpose
Selskabets formål er at drive speciallægevirksomhed og virksomhed, der er naturligt forbundet hermed
Address
Åboulevarden 17A, 1. th
Phone
+4586104300
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4.745 | 4.426 | 5.237 | 7.976 | 9.230 |
| Staff expenses | -2.628 | -2.552 | -3.280 | -4.602 | -6.256 |
| EBITDA | 1.636 | 1.374 | 1.412 | 2.850 | 2.394 |
| Depreciation & amort. | -283 | -224 | -423 | -239 | -285 |
| EBIT | 1.353 | 1.150 | 989 | 2.611 | 2.109 |
| Net financials | -55 | -87 | -65 | -69 | -29 |
| Profit before tax | 1.298 | 1.063 | 924 | 2.542 | 2.080 |
| Tax | 288 | 234 | 204 | 560 | 460 |
| Net profit | 1.010 | 830 | 720 | 1.982 | 1.620 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2.709 | 2.176 | 1.808 | 3.479 | 3.080 |
| Equity | 1.489 | 969 | 889 | 2.111 | 1.750 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.220 | 1.186 | 919 | 1.369 | 1.330 |
| Total debt | 1.220 | 1.186 | 919 | 1.369 | 1.330 |
EBITDA margin
25.9%
This company
15.8%
Market median
+64% vs market
20212025
Equity ratio
56.8%
This company
38.2%
Market median
+49% vs market
20212025
Return on equity
92.5%
This company
18.4%
Market median
+403% vs market
20212025
Net profit margin
17.5%
This company
8.1%
Market median
+116% vs market
20212025
Asset turnover
3.00×
This company
1.12×
Market median
+168% vs market
20212025
Debt / equity
0.76×
This company
0.62×
Market median
+23% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BK Management | Management | 2009 |
| Former (4) | ||
KE Management | Management | 1990 – 2009 |
ET | Audit | 1990 – 1991 |
PE Management | Management | 1990 – 1991 |
OB Management | Management | 1990 – 2002 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2009 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SPECIALLÆGE, PH.D. BO KARLSMOSE HOLDING ApS
SPECIALLÆGE, PH.D. BO KARLSMOSE ApS Board members of SPECIALLÆGE, PH.D. BO KARLSMOSE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Klaus Erik Juul Jensen | Management | 0 companies |
| Bo Karlsmose | Management | 0 companies |
| Erik Tronborg Andersen | Audit | 0 companies |
| Per Emil Hasselbalch Stakemann | Management | 0 companies |
| Ole Blegvad Andersen | Management | 0 companies |